GenMark Diagnostics, Inc. (NASDAQ: GNMK) filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of its common stock. The proposed maximum aggregate offering price is $46 million. The company plans to ...
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LJPC at https://www.zacks.com/ap/LJPC Keywords: La Jolla Pharmaceutical, Earnings Report
ETRM closed Monday's trading at $1.94, up 1.57%. In after-hours, the stock gained another 7.73% to $2.09. La Jolla Pharmaceutical Co.'s (LJPC) New Drug Application for LJPC-501 for the treatment of hypotension in adults with distributive or vasodilatory ...
RTTNews · 8mon
With analysts calling for LJPC-501 to potentially deliver peak sales in excess ... than La Jolla Pharmaceutical When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade ...
The company's stock closed at $14.25 in Friday's trading on Nasdaq. The discovery does not ensure that Agouron will develop an effective cold-fighting drug--that won't be known for several years at least. Still, the prospect of having a blockbuster in ...
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LJPC at https://www.zacks.com/ap/LJPC